Extra fingers and double hearts: Scientists decode how tiny mutations can derail development

Our genomes provide the instructions for proper growth and development. Millions of genomic switches, known as enhancers, control the location and timing of gene expression, which in turn ensures the correct proteins are made in the right cells at the right time throughout our lives.

GV backs hair loss biotech out of UCLA with PhII set for mid-2024

Pelage Pharmaceuticals, a Los Angeles-based hair loss biotech based on research out of UCLA, has reeled in a $16.75 million Series A and plans to

February 28, 2024

SK bioscience to expand vaccine manufacturing plant

Share this article SK bioscience CEO Jaeyong Ahn (fourth from left), Sanofi Korea Vaccines general manager and representative director Pascal Robin (fifth from left) and

March 8, 2024

Cancer biotech Intensity Therapeutics looks to pull in $16M+ IPO

Cancer biotech Intensity Therapeutics launched an IPO as it aims to advance a therapy being tested in sarcoma and breast cancer. The Connecticut biotech announced

July 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.